EMWA Sponsors

2023 EMWA sponsorship and partnership options are open for booking!

There are many benefits when partnering with EMWA:

  • Access to target audience of medical communicators
  • Cost-effective sponsorship opportunities
  • Longevity of partnership provides high return on investment
  • Interactive environment conducive to forging strong relationships
  • High visibility thanks to wide range of EMWA exposure (conferences, web and publications)

These opportunities suit potential sponsors of all sizes. For more information about the sponsorship opportunities or booking your opportunity for the conference, please contact: sponsorship@emwa.org 

Contact sponsorship@emwa.org for further information. 

Gold Corporate Sponsorship:

Yseop is the leader in Generative AI for regulated industries, changing the way content automation solutions are delivered with a human-centric, AI platform. Yseop is reimagining the future of scientific writing to get medicine into the hands of those who need it faster. With a suite of industry-specific applications and cutting-edge hybrid Natural Language Generation (NLG) technology that blends symbolic, machine learning, and LLM techniques, Yseop ensures that even the most demanding content automation tasks are met with ease, scalability and application security across the entire enterprise.

As the world’s leading content automation solution for biopharmaceuticals, Yseop Copilot is a digital colleague that empowers scientific writers and addresses the unique requirements of regulated industries. Blending the power of large language models with customer data, Yseop Copilot delivers trusted and auditable content automation solutions in a closed, secure environment.

Silver Corporate Sponsorship:

Taylor&Francis, also including Dove Press, publishes vital research across medicine, health, and pharmaceutical science. Research articles are assessed by independent peer reviewers for quality, validity, and relevance. Many journals in our medical portfolio are indexed in the Science Citation Index, Science Citation Index Expanded, Scopus, and MEDLINE. Like you, we value high visibility and timely publication, and offer a range of open access and accelerated publication options to help you achieve your publication goals.

Amazon’s Alexa service ranks our platform, Taylor&Francis Online, among the world’s most-visited academic journals publishing platforms so you can be confident that your work will reach the right audience at the right time.

Bronze Corporate Sponsorship:

ICON’s Global Medical Writing (MW), Quality & Editing (Q&E), and Clinical Trial Transparency (CTT) team stays abreast of the changing global regulatory environment to support and guide our clients at every stage of development. We provide world-class MW expertise across a broad range of therapeutic areas and document types. Medical Writers contribute to strategic input, authoring, and reviewing of key documents in support of clinical trials and the marketing application process (i.e., investigational new drug and new drug applications, marketing authorization applications, clinical study protocols, clinical study reports, patient narratives, investigator brochures, and other regulatory documents). ICON’s strong Q&E department provides data integrity and editorial reviews for documents produced internally or by our clients. The CTT group specializes in helping clients better understand regulations and ensures global compliance by supporting all aspects of the trial disclosure lifecycle. Our mission is to produce superior quality documents, meeting regulatory and client‑specific guidelines.

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com and follow us on LinkedIn, Twitter, Facebook and Instagram


ZYLiQ is going to give medical writers what they need… time. No more spending weeks creating Clinical Study Reports (CSRs), Medical Writers can now use their valuable time on interpretation of study results and their discussion points.

The premise is simple... Using AI, ZYLiQ allows users to automatically generate CSRs (according to ICH E3 guidelines) that would otherwise take days or months even.  The tool allows for easy Post-Text to In-Text table generation, with interpretation of tables, Synopsis summarization, automatic tense conversion, multi-authoring, consolidated view of reviewers comments and more.

ZYLiQ also has robust workflow functions, traceability reporting as well as a complete audit log.  Let ZYLiQ accomplish the tedious manual “copy/paste” aspects of a CSR and allow you to complete the report accurately and efficiently, in days instead of weeks.